“Becton Dickinson Luer Tip Caps Recall: Failed Biocompatibility Testing.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/51057-becton-dickinson-luer-tip-caps-recall-failed-biocompatibility-testing. Based on FDA recall #Z-0504-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0504-2026%22&limit=1).
The FDA announced on Oct. 14, 2025, that Becton Dickinson & Company is recalling BD Luer Tip Caps due to biocompatibility testing failures. Owners should contact the company for a remedy.
How to tell if you have it
Brand: Becton Dickinson
Product: BD Luer Tip Caps
Catalog Number/Model Number: 308341
Lot Numbers: 5029670, 5034211, 5041975
The hazard
According to the FDA, Becton Dickinson confirmed through internal testing that certain device trays failed routine biocompatibility testing.
Context
GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since May 31, 2017. Other recent recalls of similar products include Becton Dickinson Swan-Ganz Catheter Recall (April 8, 2026) and Medline Perfusion Syringe Recall (Oct. 27, 2025).
How to tell if you have this one
Check for catalog number 308341 on the Luer Tip Caps. Lot numbers 5029670, 5034211, and 5041975 are also associated with this recall.
Brand
Becton Dickinson
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for catalog number 308341 or lot numbers 5029670, 5034211, 5041975 on the Luer Tip Caps.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 36 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution including in the states of AL, AZ, CA, CO, FL, GA, HI, IA, ID, IL, IN, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Canada,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin.
Recall timeline
FDA published this recall 43 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0504-2026 (October 14, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0504-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.